Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis    NOVN   CH0012005267

NOVARTIS (NOVN)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Novartis
Manufactures and markets health care and nutritional products

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products.

It operates through the following segments: Innovative Medicines, Alcon, Sandoz, and Corporate.

The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals.

The Alcon segment researches, develops, manufactures, distributes and sells eye care devices and vision care.

The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients.

The Corporate segment refers to group management and central services.

The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Number of employees : 121 597 persons.
Sales per Businesses
20162017Delta
CHF (in Million)%CHF (in Million)%
Innovative Medicines32,07967.1%32,50567.2% +1.33%
Sandoz9,99420.9%9,90220.5% -0.92%
Alcon5,72612%5,92912.3% +3.55%
Sales per Regions
20162017Delta
CHF (in Million)%CHF (in Million)%
Other19,80041.4%20,49342.4% +3.5%
United States16,86335.3%16,66934.5% -1.15%
Germany3,5807.5%3,6327.5% +1.45%
Japan3,2196.7%3,1276.5% -2.84%
France2,3554.9%2,4515.1% +4.09%
United Kingdom1,1642.4%1,1422.4% -1.95%
Switzerland817.691.7%822.841.7% +0.63%
Managers
NameAgeSinceTitle
Vasant Narasimhan, MD422005Chief Executive Officer
Jörg Reinhardt622013Independent Non-Executive Chairman
Harry Werner Kirsch532003Chief Financial Officer
John Tsai, MD512018Chief Medical Officer
Srikant Madhav Datar, PhD642003Independent Non-Executive Director
Andreas von Planta, PhD632006Independent Non-Executive Director
Ann Marie Fudge, MBA672008Independent Non-Executive Director
Enrico Cipro Vanni PhD, MBA672011Vice Chairman
Dimitri Azar MD, EMBA592012Independent Non-Executive Director
Charles L. Sawyers, MD592013Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 2,550,624,820 2,162,895,730 84.8% 228,884,480 9.0% 84.8%
Shareholders
NameEquities%
Novartis AG 97,969,738 3.84%
Sandoz Family Foundation 88,972,723 3.49%
Novartis Foundation For Employee Participation 65,421,120 2.56%
The Vanguard Group, Inc. 58,427,792 2.29%
Norges Bank Investment Management 54,693,999 2.14%
UBS AG (Investment Management) 42,494,919 1.67%
Capital Research & Management Co. (Global Investors) 41,665,076 1.63%
Wellington Management Co. LLP 32,194,781 1.26%
BlackRock Fund Advisors 30,399,464 1.19%
Capital Research & Management Co. (World Investors) 23,982,051 0.94%
Holdings
NameEquities%Valuation
Roche Holding (RO) 53,332,86333.3%12,031,382,431 USD
Novartis India Limited (NOIN) 17,450,68070.7%170,049,547 USD
Mereo BioPharma Group plc 13,767,84119.4%56,712,215 USD
Arrowhead Pharmaceuticals Inc (ARWR) 3,321,3833.79%45,170,809 USD
Aerpio Pharmaceuticals Inc (ARPO) 5,805,55014.9%24,093,033 USD
Aduro BioTech Inc (ADRO) 3,170,5284.03%22,193,696 USD
Oxford BioMedica plc 1,415,5602.15%18,425,424 USD
XOMA Corp (XOMA) 539,1316.44%11,257,055 USD
GenSight Biologics (SIGHT) 3,521,77414.5%10,978,637 USD
BioLineRX Ltd. 5,000,0004.63%4,474,400 USD
Markets and indexes
- SIX Swiss Exchange
- Main Standard
- FTSE Eurotop 100 / Low Carbon 100 Europe, SMI, Stoxx Europe 50, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  
- Reuters Code :  NOVN.S
- Datastream Code :  S:NOVS
Company contact information
Novartis
35 Lichtstrasse
CH-4002 Basel, Basel-Stadt
Switzerland

Phone : +41 61 324 79 44
Fax : +41 61 324 8001
Internet : http://www.novartis.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
NOVARTIS-1.75%206 705
JOHNSON & JOHNSON-9.93%337 790
PFIZER3.06%218 540
ROCHE HOLDING LTD.-5.90%200 737
MERCK AND COMPANY11.11%168 171
AMGEN9.54%126 889
ABBOTT LABORATORIES10.95%111 818
SANOFI0.71%105 544
GLAXOSMITHKLINE17.19%101 446
BAYER-10.06%100 917
ELI LILLY AND COMPANY4.75%97 070
NOVO NORDISK A/S-4.90%95 716
ASTRAZENECA9.14%92 447
BRISTOL-MYERS SQUIBB COMPANY-7.46%92 417
CELGENE CORPORATION-18.46%61 857
ALLERGAN PLC5.02%58 790
SHIRE12.37%52 878
JIANGSU HENGRUI MEDICINE CO LTD38.09%40 172
TAKEDA PHARMACEUTICAL CO LTD-27.26%33 746
ASTELLAS PHARMA INC24.76%32 108
EISAI CO., LTD71.62%29 654
Connections : Novartis
Novartis Institutes for Biomedical Research, Inc.
Chicago Medical Society Foundation
The Rockefeller Foundation
International Federation of Pharmaceutical Manufacturers
Novartis Vaccines & Diagnostics, Inc.
Weill Cornell Graduate School of Medical Sciences
Novartis Pharma KK
National Academy of Medicine of United States
The Brookings Institution
T-Mobile USA, Inc.
Banque Privée BCP (Suisse) SA
Novartis, Inc.
The Genomics Institute of the Novartis Research Foundation
American Academy of Arts & Sciences
Harvard Business School
SIX Swiss Exchange AG
American Accounting Association
Institute of Management Accountants, Inc.
Simmons College (Massachusetts)
Chicago Ophthalmological Society
US Department of State (District of columbia)
Verb Surgical, Inc.
Denzler & Partners
American Ophthalmological Society
Jan Autos Holding SA
Cold Spring Harbor Laboratory, Inc.
The Association for Research in Vision & Ophthalmology
Raymond Weil SA
Tear Film & Ocular Surface Society
HSBC Private Banking Holdings (Suisse) SA
University of Illinois
Socotab Frana SA
Verily Life Sciences LLC
Generale Beaulieu Holding SA
Boston Millennia Partners
AP Møller Finance SA
National Academy of Sciences
Burberry Suisse SA
Oric Pharmaceuticals, Inc.
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem